PPARγ agonist alleviates calcium oxalate nephrolithiasis by regulating mitochondrial dynamics in renal tubular

Junfa Liu1, Xingyang Liu2, Lizhe Guo2

  • 1Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, China.

Plos One
|September 26, 2024
PubMed
Abstract

Insights

Calcium oxalate crystals damage kidney cells by increasing mitochondrial fission and apoptosis. Targeting mitochondrial dynamics offers a promising therapeutic strategy for kidney stones.

Area of Science:

  • Nephrology
  • Cell Biology
  • Biochemistry

Background:

  • Kidney stones, particularly calcium oxalate stones, pose a significant health risk.
  • The precise mechanisms by which calcium oxalate crystals damage renal tubular epithelial cells are not fully understood.
  • The role of mitochondrial dynamics in calcium oxalate nephrolithiasis remains unclear.

Purpose of the Study:

  • To investigate the effects of calcium oxalate crystals on mitochondrial dynamics and apoptosis in renal tubular epithelial cells.
  • To explore the potential of regulating mitochondrial dynamics as a therapeutic strategy for calcium oxalate nephrolithiasis.

Main Methods:

  • An in vivo rat model of calcium oxalate nephrolithiasis was established using ethylene glycol administration.
  • In vitro studies utilized HK2 cells exposed to calcium oxalate crystals.
  • Kidney tissues and blood samples were analyzed for histopathology, oxidative stress, inflammation, fibrosis, and mitochondrial dynamics.

Main Results:

  • Calcium oxalate crystals induced significant mitochondrial fission and apoptosis in renal tubular epithelial cells.
  • Treatment with a PPARγ agonist ameliorated mitochondrial fission and apoptosis, improved renal function, and reduced oxidative stress, inflammation, and fibrosis.
  • Increased mitochondrial fission was linked to reactive oxygen species accumulation and apoptosis initiation.

Conclusions:

  • Mitochondrial fission is a key factor in kidney injury induced by calcium oxalate stones.
  • Regulating mitochondrial dynamics presents a potential therapeutic avenue for treating calcium oxalate nephrolithiasis.